Groupama Asset Managment Purchases New Holdings in GE HealthCare Technologies Inc. $GEHC

Groupama Asset Managment acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 8,785 shares of the company’s stock, valued at approximately $660,000.

A number of other hedge funds have also recently bought and sold shares of GEHC. E Fund Management Hong Kong Co. Ltd. increased its stake in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the period. Godsey & Gibb Inc. bought a new stake in shares of GE HealthCare Technologies during the third quarter worth $26,000. Oakworth Capital Inc. lifted its stake in shares of GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after acquiring an additional 394 shares during the period. Piscataqua Savings Bank boosted its holdings in GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after acquiring an additional 300 shares during the last quarter. Finally, Salomon & Ludwin LLC boosted its holdings in GE HealthCare Technologies by 326.5% in the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock valued at $37,000 after acquiring an additional 369 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Down 1.1%

Shares of NASDAQ GEHC opened at $69.61 on Friday. The stock has a market cap of $31.72 billion, a P/E ratio of 15.26, a P/E/G ratio of 1.55 and a beta of 1.03. The firm has a 50 day moving average price of $79.22 and a 200 day moving average price of $78.38. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

Analyst Ratings Changes

Several brokerages have weighed in on GEHC. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Jefferies Financial Group boosted their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, Evercore increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.